Including Fibroblast Growth Factor-21 in Combined Biomarker Panels Improves Predictions of Liver Steatosis Severity in Children

Background: Previous studies reported conflicting results regarding the association between fibroblast growth factor-21 (FGF-21) and non-alcoholic fatty liver disease (NAFLD). This study aimed to evaluate the feasibility of combining FGF-21, obesity indices, and biochemical tests for predicting high...

Full description

Bibliographic Details
Main Authors: Man-Chin Hua, Jing-Long Huang, Ching-Chih Hu, Tsung-Chieh Yao, Ming-Wei Lai
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Pediatrics
Subjects:
BMI
Online Access:https://www.frontiersin.org/article/10.3389/fped.2019.00420/full